Oct1/2

Oct1/2 Constitutive Knockout Mouse Model
  • Cryopreserved
  • Mouse
  • Not available for direct purchase by CRO
Model No.NomenclatureGenotype
6622 FVB.129P2-Slc22a1tm1Ahs  Slc22a2tm1Ahs N7Inquire for genotype
View:
Select One

Overview

Nomenclature: FVB.129P2-Slc22a1tm1Ahs  Slc22a2tm1Ahs N7

  • This double targeted mutation strain carries a disruption of organic cation transporter genes Slc22a1 and Slc22a2
  • Useful for studies of drug transport in the liver, intestine and kidneys
  • OCT1 and OCT2 determine renal secretion of small organic cations
Orders by weight: Taconic cannot accept orders by weight for this model. Please note that shipments may contain animals with a larger weight variation.

Origin

The Oct1/2 mouse was developed in the laboratory of Alfred Schinkel of the Netherlands Cancer Institute. The model was created through sequential targeting of the Slc22a1 and Slc22a2 genes in 129/Ola-derived E14 ES cells and injecting the targeted cells into C57BL/6 blastocysts. Resultant chimeras were backcrossed to FVB/N for seven generations (N7). Taconic received stock in 2006, and the line was embryo transfer derived. The colony was maintained by mating doubly homozygous mice.

Want to Get in Touch?

Chat with us or reach out to our global team

phone

2025 Pricing Guide Now Available

Get your Taconic Biosciences 2025 Pricing Guide today. Personalized, customizable, links to up-to-date health reports, and additional information on Taconic's products and services.

Pricing Guide